1. Lilly and BI tout new kidney disease data for Jardiance — Insulin providers prep for Brexit fallout — IGM updates its IPO, may raise over $200M — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Interview

Discussion in 'Kimberly-Clark' started by Anonymous, Jan 17, 2012 at 4:21 PM.

  1. Anonymous

    Anonymous Guest

    I made next level in the interview process for a OR medical supplies division. I'm on the fence since I've researched KC offers low base compared to other companies. Can someone with an open mind tell the pluses and minuses of KC? I am currently with a capital sales company and word is changes are coming in 2012. Any information on salary, benefits etc would be appreciated.
     
  2. Anonymous

    Anonymous Guest

    You will probably see a lot of negative reviews on this sight, but you probably will see the same for every other company.

    Most of these posts have to do with the device side of things, and that is where I am. However, I do have friends on the other side of the bag, and most of them have done pretty well over the last couple of years. KC is a better supply company than device at this point. They have a good reputation on that side of things.

    Overall, KC is a very large, conservative, stable company. Check out the financials. It is not going anywhere. Especially the supplies. As far as your success goes, it will depend on the contract situation with your products in your area. That would be a good question to ask. Also, I have heard there has been price increase for raw materials for gloves. I would ask about that, also.
     
  3. Anonymous

    Anonymous Guest

    You live and die with the GPO contracts for drapes and gowns. There is no significant clinical difference between Cardinal, Medline and KC anymore so it is all about the price. KC is getting out of the nitrile glove business, reps told to maintain current business but not to take on new customers. Pretty much a howdy doody job now, bagles and doughnuts for the customers. Oh yeah, with 95+% of wrap market, no where to go but down when Cardinal releases their wrap this year.
     
  4. Anonymous

    Anonymous Guest

    Don't know what kind of base you're being offered but KC's base seemed very high to me but very low commission. So not really sure who you're speaking to.
     
  5. Anonymous

    Anonymous Guest

    Don't be a fool and sign on this company!!! The medical device products such and Trach Care and MIC-key have been around since the early 1980's and their is nothing on the horizon unless you count that idiotic subglotic tube which ain't going to sell at $17. KC Healthcare is on a death spiral, they will be sold off in whole or pieces. Guess who gets the ax from the new owner??????
     
  6. Anonymous

    Anonymous Guest

    The sales force per product category is not needed the volumes are to small. Top management has driven this company to shambles!!!!!!!yes the new owners will find out quickly. Do not forget top gang will have a golden parachute to retain people (if needed until after the sale).
    Just keep saying everything is fine. All will be ok we are better off. We make money.
     
  7. Anonymous

    Anonymous Guest

    That's why a lot of us are looking. It's not a matter of if as it's more a matter of when the layoffs will happen. Be smart and don't be fooled. Look what happened last January. The ax fell. Look what just happened to supplies. History repeats itself. No new products year after year. It's not a bad company just not stable. You're better off looking elsewhere. You want a progressive company that's coming out with new products. Respiratory products are all commodities. As far as DH, How do you continue to grow MIC-Key business year after year when your the market leader and have nothing new to offer? Just my two cents.

    Management is ok but R&D has not done much of anything. The big shots are cashing in on stock like never before. It's us poor slobs that get a mediocre base salary at best and a large amount of the sales force not hitting plan which means you're not even getting you full commission. Don't count on stock options. We don't get any. I've never seen a company so cheap. I cashed out about $40k in stock from my previous company. Do you think we would get anything? Even a small amount would be a nice gesture, but nothing.

    Keep looking. Better things are out there.
     
  8. Anonymous

    Anonymous Guest

    They drove the company into cutting prices to compete because there is no difference in quality of goods or services. Old technology while all other companies have advance in quality and technology. Good job Joanne and crew.
     
  9. Anonymous

    Anonymous Guest

    So true